Warren Davidson - Integrity Index View Warren Davidson's political integrity grade, campaign financing, and conflicts of interest.

Rep. Warren Davidson (R-OH) disclosed 1 trade:
Traded: Mar 23 | Disclosed: Mar 25

Sold: $GEHC ($1K-$15K)

https://integrityindex.us/candidate/warren-davidson

We are delighted to announce a collaboration between @bilih.bsky.social #BILIH & GEHealthCare #GEHC

@jeffgadsden.bsky.social & I bring to you a series of Video Scanning Podcasts, including 2 sessions where we answer all your questions

Free Registration 👇🏽👇🏽👇🏽
bit.ly/3PvuXi4

GE HealthCare’s Photonova Spectra photon-counting CT receives FDA clearance GE HealthCare has received 510 clearance from the U.S. Food and Drug Administration for Photonova™ Spectra, i an innovative photon‑ counting computed tomography solution powered by the company’ s novel Deep Silicon detector technology and offered as a flexible platform with multiple configurations to meet diverse clinical needs. “As clinicians across the...

#GEHC GE HealthCare’s Photonova Spectra photon-counting CT receives FDA clearance

www.stocktitan.net/news/GEHC/ge-health-care...

GE HealthCare announces U.S. FDA 510(k) clearance for View, a next‑generation diagnostic viewer enabling anywhere‑access to radiologists GE HealthCare (NYSE:GEHC) announced on March 9, 2026 that View, the diagnostic viewer in the Genesis Radiology Workspace, received U.S. FDA 510(k) clearance. View is a cloud‑native, zero‑footprint diagnostic viewer offering high‑performance 2D/3D visualization, AI‑enabled tools, and direct access to Advanced Visualization in a single workflow.The product aims to reduce radiologist non‑interpretive time (studies cite up to 44%) and enable remote, secure diagnostic access; availability varies by region.

#GEHC GE HealthCare announces U.S. FDA 510(k) clearance for View, a next‑generation diagnostic viewer enabling anywhere‑access to radiologists

www.stocktitan.net/news/GEHC/ge-health-care...

We had such a great time with @noolslucas.bsky.social covering Obs Anaesthesia in the #GEHC #BlockBox for @bilih.bsky.social #BILIH .

She did tell @jeffgadsden.bsky.social and I a couple of jokes at end though!

Full episode: www.blockitlikeitshot.com/s4-e1-block-...

@oaa-anaes.bsky.social

#GEV #GE #GEHC #9c568685-bb7b-4e53-9604-b079710af373 #investing #Industrials

Origin | Interest | Match

GE HealthCare and Indonesia’s Ministry of Health to expand access to quality care through the provision of 300+ advanced CT scanners GE HealthCare today announced it will supply more than 300 CT scanners under Indonesia’ s Strengthening Indonesia’ s Health Referral Network program to deliver equitable, high-quality care to more than 280 million Indonesians. As part of a competitively awarded, multi-year contract, GE HealthCare will supply the advanced CT scanners to public hospitals...

#GEHC GE HealthCare and Indonesia’s Ministry of Health to expand access to quality care through the provision of 300+ advanced CT scanners

www.stocktitan.net/news/GEHC/ge-health-care...

GE HealthCare (Nasdaq: GEHC), Mayo Clinic unveil GEMINI-RT to advance AI-guided radiation therapy GE HealthCare and Mayo Clinic launch GEMINI-RT to integrate imaging, AI and monitoring across radiation therapy, used in over 50% of cancer cases and 2M U.S. patients.

#GEHC GE HealthCare and Mayo Clinic unveil GEMINI-RT: A bold research collaboration in radiation therapy and advanced cancer care

www.stocktitan.net/news/GEHC/ge-health-care...

University of Rochester Medical Center and GE HealthCare form seven-year Care Alliance to build advanced capabilities across system University of Rochester Medical Center and GE HealthCare (Nasdaq: GEHC) launched a seven-year Care Alliance on December 3, 2025 to standardize imaging and monitoring across UR Medicine.The program includes upgrades and new MRI, Aurora SPECT/CT, dual-energy CT, LOGIQ E10 ultrasound, on-device AI, a Continuum+ software upgrade path, plans for an on-site cyclotron to produce radiopharmaceutical tracers, and system-wide Carescape ONE monitoring powered by Carescape Canvas.

#GEHC University of Rochester Medical Center and GE HealthCare form seven-year Care Alliance to build advanced capabilities across system

www.stocktitan.net/news/GEHC/university-of-...

#ISRG #GEHC #7c60fb4d-7a5a-4243-b7ac-76424e3d0fe8 #investing #Health #Care

Origin | Interest | Match

GE HealthCare to acquire Intelerad, advancing cloud-enabled enterprise imaging across care settings GE HealthCare announced it has entered into an agreement to acquire Intelerad, a leading medical imaging software provider for the healthcare industry, for a purchase price of $2.3 billion paid in cash. This acquisition demonstrates GE HealthCare’ s continued commitment to cloud-enabled and AI-powered solutions across care settings and furthers the...

#GEHC GE HealthCare to acquire Intelerad, advancing cloud-enabled enterprise imaging across care settings

www.stocktitan.net/news/GEHC/ge-health-care...

GE HealthCare reports third quarter 2025 financial results GE HealthCare (Nasdaq: GEHC) reported third-quarter 2025 results for the period ended September 30, 2025. Revenues were $5.1 billion, up 6% reported and 4% organic year‑over‑year, with total company orders +6% organic and a book‑to‑bill of 1.06. Net income attributable to GE HealthCare was $446 million; diluted EPS was $0.98 and Adjusted EPS was $1.07. Adjusted EBIT margin was 14.8% and free cash flow was $483 million. The company raised the lower end of full‑year 2025 Adjusted EPS guidance to a range of $4.51 to $4.63 and reaffirmed other metrics while noting approximately $265 million of tariff impact to Adjusted EBIT and $0.45 to Adjusted EPS.

#GEHC GE HealthCare reports third quarter 2025 financial results

www.stocktitan.net/news/GEHC/ge-health-care...

GE HealthCare collaborates with two major medical systems to advance AI technology designed to transform hospital operations and improve patient care GE HealthCare (Nasdaq: GEHC) on October 20, 2025 announced collaborations with The Queen’s Health Systems and Duke Health to co‑develop a new AI‑driven, cloud‑first hospital operations application in its CareIntellect family.The solution will use predictive analytics to recommend actions across bed demand, staffing, and equipment, drawing on insights from ~500 hospitals (55,000 beds) that use Command Center. Queen’s cited measurable results: 22.2% jump in transfer admissions, 41.2% ED length‑of‑stay reduction, 1.07 day overall LOS drop, and $20M estimated first‑year savings.

#GEHC GE HealthCare collaborates with two major medical systems to advance AI technology designed to transform hospital operations and improve patient care

www.stocktitan.net/news/GEHC/ge-health-care...

Our latest Episode of #BILIH @bilih.bsky.social is a pure videocast!
In this episode, @jeffgadsden.bsky.social & I stepped into the future with @dr-rajgupta.bsky.social in the #GEHC BlockBox at the #ASRASpring25 meeting!
Check out the full episode:
www.blockitlikeitshot.com/videos/welco...

University of Michigan study presentation at ANESTHESIOLOGY 2025 supports clinical and environmental benefits of End-tidal Control GE HealthCare (Nasdaq: GEHC) presented University of Michigan findings at ANESTHESIOLOGY 2025 (Oct 10–14) showing End-tidal Control software was associated with lower anesthetic use and emissions in real-world care. The retrospective analysis covered 14,730 adult general anesthesia cases, with End-tidal Control used in 50.5% of cases and active for 82.1% of the maintenance phase. Preliminary results reported reductions of greater than 35% in fresh gas flow, sevoflurane utilization and CO2 emissions during maintenance. The release notes prior GE funding of the study and references additional supporting abstracts and a separate Missouri study with similar lower-flow and cost findings.

#GEHC University of Michigan study presentation at ANESTHESIOLOGY 2025 supports clinical and environmental benefits of End-tidal Control

www.stocktitan.net/news/GEHC/university-of-...

GE HealthCare reports second quarter 2025 financial results GE HealthCare (Nasdaq: GEHC) reported strong Q2 2025 financial results with revenue growth of 3% year-over-year to $5.0 billion. The company achieved net income of $486 million with a margin of 9.7%, up from 8.9% in the prior year. Diluted EPS increased to $1.06 from $0.93.The company raised its full-year 2025 guidance, projecting organic revenue growth of approximately 3% and adjusted EBIT margin of 15.2% to 15.4%. Free cash flow guidance was increased to at least $1.4 billion, up from the previous $1.2 billion target. Performance was driven by strong orders across all segments, particularly in the U.S. and EMEA regions, despite tariff impacts.

#GEHC GE HealthCare reports second quarter 2025 financial results

www.stocktitan.net/news/GEHC/ge-health-care...

GE HealthCare drives growth with investment in AI-enabled medical devices and tops FDA’s list of AI authorizations for 4th Year with 100 GE HealthCare (Nasdaq: GEHC) has achieved a significant milestone by leading the FDA's AI-enabled medical device authorizations list for the fourth consecutive year, securing 100 authorizations to date. The company is advancing toward its goal of obtaining more than 200 authorizations by 2028.The company's AI solutions span multiple areas including oncology, cardiology, and neurology, featuring innovative products such as AI-based Auto Positioning for CT and PET/CT devices, AIR™ Recon DL for MRI imaging with up to 50% faster scan times, and the LOGIQ™ Series ultrasound systems with AI-powered automation.This achievement reflects GE HealthCare's strategic focus on R&D investment in AI-enabled medical devices, designed to enhance healthcare efficiency, improve diagnostic confidence, and address challenges such as care team shortages and rising costs.

#GEHC GE HealthCare drives growth with investment in AI-enabled medical devices and tops FDA’s list of AI authorizations for 4th Year with 100

www.stocktitan.net/news/GEHC/ge-health-care...

I’ve just released a video on my channel trying to demystify the Ultrasound Guided Ankle Block.

This is a “stripped back” demo, on a #GEHC #VenueGo

The aim is to mimic teaching you might get on a workshop
Let me know what you think
Video available here:👇🏼

youtu.be/Bl0_x-hn3yA?...

FDA Approves Expanded Indications for GE HealthCare’s Vizamyl PET Imaging Agent for Beta Amyloid Detection, Enabling More Precise Care for Alzheimer’s Patients GE HealthCare (NASDAQ: GEHC) has received FDA approval for expanded indications of its Vizamyl PET imaging agent for beta-amyloid detection. The updated label now includes quantification capabilities for more objective amyloid measurements in the brain and removes previous limitations.Key updates include the ability to monitor patient response to anti-amyloid therapies, predict development of dementia due to Alzheimer's disease, select patients for anti-amyloid therapies, and establish Alzheimer's disease diagnosis. The quantification feature enables calculation of amyloid load, improving diagnostic confidence and consistency among readers.

#GEHC FDA Approves Expanded Indications for GE HealthCare’s Vizamyl PET Imaging Agent for Beta Amyloid Detection, Enabling More Precise Care for Alzheimer’s Patients

www.stocktitan.net/news/GEHC/fda-approves-e...

Pioneering precision: GE HealthCare aims to elevate clinical care through total body PET/CT technology with Stanford Medicine GE HealthCare (GEHC) has renewed its research collaboration with Stanford Medicine to advance total body PET/CT technology, aiming to enhance clinical care and patient outcomes. The partnership focuses on developing next-generation imaging solutions that offer ultra-high sensitivity, reduced scan times, and improved diagnostic capabilities. The technology is designed to support personalized medicine practices, particularly in oncology, pediatric imaging, and theranostics. Key features include ultra-low dose scans, fast acquisitions, multi-organ dynamic imaging, and dual tracer imaging. Stanford Medicine experts highlight the technology's potential to revolutionize molecular imaging studies, reduce anesthesia use in pediatric cases, and improve healthcare system efficiency. This collaboration builds on GE HealthCare's history of innovation in medical imaging, including their development of the first commercially available PET/CT solution.

#GEHC Pioneering precision: GE HealthCare aims to elevate clinical care through total body PET/CT technology with Stanford Medicine

www.stocktitan.net/news/GEHC/pioneering-pre...

www.fool.com/investing/2025/06/04/3-t...

#GEHC #NVDA #ETN #PTC #SBGSF #VRT #8be8e750-3f9f-4f8b-ae59-0c7f71f5fe66 #investing

Result Details

Updated NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Recommend Use of FES PET Imaging for Lobular Breast Cancer GE HealthCare (GEHC) announced that NCCN Guidelines now recommend fluoroestradiol (FES) PET imaging for systemic staging in patients with recurrent or metastatic lobular breast cancer. The company's Cerianna (fluoroestradiol F18) injection is the only FDA-approved imaging agent for detecting estrogen receptor positive (ER+) breast cancer metastases. This update expands the 2023 guidelines that included FES PET for systemic staging of recurrent/stage IV ER+ breast cancer. Invasive lobular cancer (ILC) represents 10-15% of all breast cases, with approximately 43,000 new cases annually, and 95% of ILC tumors are ER+. The guidelines' update could improve diagnostic accuracy, facilitate earlier interventions, enhance clinical decision-making, and potentially lead to broader insurance coverage for breast cancer patients.

#GEHC Updated NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Recommend Use of FES PET Imaging for Lobular Breast Cancer

www.stocktitan.net/news/GEHC/updated-nccn-c...

Our 1st Instalment of @bilih.bsky.social at #ASRASpring25 with #GEHC is out!

You can claim your CME by texting the code HURKAY to the number as before.

@jeffgadsden.bsky.social 👌🏾🙏🏽

Full episode links

open.spotify.com/episode/5v2V...

podcasts.apple.com/gb/podcast/b...

#RAsky #AnSky

GE HealthCare's New AI Technology Achieves 98% Clearer Medical Images, Revolutionizing Interventional Procedures Revolutionary AI-powered CleaRecon DL delivers 98% clearer CBCT images for precision interventional procedures. FDA-cleared technology transforms medical imaging. Learn more.

#GEHC GE HealthCare launches CleaRecon DL, introducing AI-based 3D reconstruction to the interventional suite

www.stocktitan.net/news/GEHC/ge-health-care...

GE HealthCare Announces FDA Approval of Pediatric Indication for Optison Ultrasound Enhancing Agent GE HealthCare (GEHC) has received FDA approval for pediatric use of its Optison ultrasound enhancing agent. Optison, which contains gas-filled microbubbles that enhance ultrasound wave reflection, helps provide clearer echocardiogram images for diagnosing heart conditions. As the only PEG-free ultrasound enhancing agent in the U.S., it offers a safe option for patients with PEG hypersensitivity. The approval follows a Phase IV study demonstrating Optison's effectiveness in pediatric patients by improving endocardial border delineation and left ventricular wall segment visualization. Originally approved for adults in 1997, Optison has been administered to over 5 million patients in the U.S. This expansion to pediatric patients represents a significant milestone for GE HealthCare's Pharmaceutical Diagnostics segment, which supported 130 million patient procedures in 2024.

#GEHC GE HealthCare Announces FDA Approval of Pediatric Indication for Optison Ultrasound Enhancing Agent

www.stocktitan.net/news/GEHC/ge-health-care...

www.fool.com/investing/2025/05/12/her...

#GEHC […]

[Original post on fool.com]